Lilly Acquires Centessa to Expand Sleep Disorder Pipeline
Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders
/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage company developing a new class of medicines...
Eli Lilly is acquiring Centessa Pharmaceuticals in a strategic move to advance its portfolio of sleep-wake disorder treatments. The clinical-stage company brings novel therapeutics that complement Lilly's existing neuroscience pipeline. This acquisition strengthens Lilly's position in the growing sleep medicine market.
Original Article
Read full article on PR Newswire: press release distribution, targeting, monitoring and marketingExplore More
Related News
Bondi struggled to prosecute Trump foes. But will a new attorney general make a difference?
Anchorage Daily News · 2026.04.05
German men aged 17-45 may need military approval for long stays abroad
BBC · 2026.04.05
Basketball Hall of Fame announces 2026 inductees
https://www.westernmassnews.com · 2026.04.05
Germany's Overlooked Exit Rule: Men Aged 17 to 45 Now Need Bundeswehr Permission to Leave - IMI Daily
IMI - Investment Migration Insider · 2026.04.05
Former Iowa State star Bridget Carleton taken first in WNBA expansion draft
KCCI · 2026.04.05
Virginia Announces Leadership Change for Women’s Basketball
Virginia Cavaliers Official Athletic Site · 2026.04.05